
Professor Jing-Bao Nie.
A University of Otago bioethicist has added his voice to a global plea for a moratorium on heritable genome editing from a group of international scientists and ethicists in the wake of the recent Chinese experiment aiming to produce HIV immune children.
In an article in the latest issue of international scientific journal Nature, Professor Jing-Bao Nie together with another 16 academics from seven countries, call for a global moratorium on all clinical uses of human germline editing to make genetically modified children.
They would like an international governance framework – in which nations voluntarily commit to not approve any use of clinical germline editing unless certain conditions are met – to be created potentially for a five-year period.
Professor Nie says the scientific scandal of the experiment that led to the world’s first genetically modified babies raises many intriguing ethical, social and transcultural / transglobal issues. His main personal concerns include what he describes as the “inadequacy” of the Chinese and international responses to the experiment.
“The Chinese authorities have conducted a preliminary investigation into the scientist’s genetic misadventure and issued a draft new regulation on the related biotechnologies. These are welcome moves. Yet, by putting blame completely on the rogue scientist individually, the institutional failings are overlooked,” Professor Nie explains.
“In the international discourse, partly due to the mentality of dichotomising China and the West, a tendency exists to characterise the scandal as just a Chinese problem. As a result, the global context of the experiment and Chinese science schemes have been far from sufficiently examined.”
The group of 17 scientists and bioethicists say it is imperative that extensive public discussions about the technical, scientific, medical, societal, ethical and moral issues must be considered before germline editing is permitted. A moratorium would provide time to establish broad societal consensus and an international framework.
“For germline editing to even be considered for a clinical application, its safety and efficacy must be sufficient – taking into account the unmet medical need, the risks and potential benefits and the existence of alternative approaches,” the opinion article states.
Although techniques have improved in recent years, germline editing is not yet safe or effective enough to justify any use in the clinic with the risk of failing to make the desired change or of introducing unintended mutations still unacceptably high, the scientists and ethicists say.
“No clinical application of germline editing should be considered unless its long-term biological consequences are sufficiently understood – both for individuals and for the human species.”
The proposed moratorium does not however, apply to germline editing for research uses or in human somatic (non-reproductive) cells to treat diseases.
Professor Nie considers it significant that current presidents of the UK Royal Society, the US National Academy of Medicine and the Director and Associate Director of the US National Institute of Health have expressed their strong support for such a proposed global moratorium in two correspondences published in the same issue of Nature. The editorial in the issue also argues that the right decision can be reached “only through engaging more communities in the debate”.
“The most challenging questions are whether international organisations and different countries will adopt a moratorium and if yes, whether it will be effective at all,” Professor Nie says.
Learn more: Otago bioethicist adds voice to global plea for moratorium on heritable genome editing
The Latest on: Heritable genome editing
[google_news title=”” keyword=”heritable genome editing” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Heritable genome editing
- CRISPR Gene Editing Newson September 26, 2023 at 5:00 pm
Sep. 15, 2023 — Researchers have developed a novel genome editing technique known as NICER, which results in significantly fewer off-target mutations than CRISPR/Cas9 editing. The technique uses ...
- New center provides resources to develop and test new genome editing technologieson September 26, 2023 at 5:00 am
Researchers at Baylor College of Medicine and Rice University received a grant for more than $3.9 million over five years from the National ...
- New gene-editing tool reduces unintended mutations by more than 70%on September 21, 2023 at 8:10 pm
Researchers have found that splitting the gene editor used in traditional CRISPR technology creates a more precise tool that can be switched on and off, with significantly less chance of causing ...
- 7 Top Gene-Editing Stocks to Buyon September 21, 2023 at 12:49 pm
Many gene-editing stocks have taken a hit in the past year, but analysts at Strategic Market Research still expect the genome-editing market to grow 17.3% annually and reach $21.3 billion by 2030.
- Genome Editing Market Outlook for Forecast Period (2023 to 2030)on September 20, 2023 at 10:59 pm
Explore our report to unlock the potential of the Genome Editing market and steer your business towards growth and success. The global Genome Editing market size was valued at USD 7377.87 million ...
- Genome editing: Reducing off-target mutations in DNAon September 14, 2023 at 5:00 pm
Genome editing: Reducing off-target mutations in DNA. ScienceDaily . Retrieved September 25, 2023 from www.sciencedaily.com / releases / 2023 / 09 / 230915105612.htm ...
- Genome Editing Accuracy to Get a Closer Look with BioSkryb Joining NISTon September 13, 2023 at 10:40 am
Now BioSkryb announced that it has joined the NIST Genome Editing Consortium to help address the standards needed to increase confidence of using genome editing technologies in research and ...
- BioSkryb Genomics Joins NIST Genome Editing Consortium to Define Standards in Genome Editing Research and Commercializationon September 13, 2023 at 7:52 am
Genome editing has revolutionized the treatment of devastating inherited disorders and is aiding researchers in finding cures to complex diseases. Industry experts are still working to understand ...
- 2023 Genome Editing/Genome Engineering Market: Leading Players Developments, Innovations, and Advanced Technologies, Forecast 2030on September 10, 2023 at 10:33 am
Genome Editing/Genome Engineering Market Report Overview: The Global Genome Editing/Genome Engineering market is expected to experience significant growth between 2023 and 2030. In 2022 ...
- The Transformative, Alarming Power of Gene Editingon September 1, 2023 at 11:00 pm
Some seventy other countries limit heritable genome editing; there are explicit prohibitions in Canada, Brazil, Israel, South Korea, Japan, and Australia. But there is nothing approaching an ...
via Bing News